BRAD GOLDWORM: Open Payments
NPI 1295889087 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 25 payments from 10 companies in 2025. Trend: 2023 $447 · 2024 $886 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $188 |
| Nalu Medical, Inc. | 2 | $141 |
| Collegium Pharmaceutical, Inc. | 8 | $138 |
| Virtus Pharmaceuticals LLC | 3 | $63 |
| DJO, LLC | 1 | $47 |
| Azurity Pharmaceuticals, Inc. | 1 | $32 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $22 |
| BIOTRONIK NRO, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
Products named: Nalu Neurostimulation System, Intracept, XTAMPZA, LEVORPHANOL TARTRATE, General - Pain Management, Belbuca, DONJOY, HORIZANT.
Industry payments across WA — which companies pay providers there.
